288
Views
3
CrossRef citations to date
0
Altmetric
Articles

Providing Support for Athletes With Negative Experiences During Urine Doping Controls

&

REFERENCES

  • Alfermann, D., & Stambulova, N. (2007). Career transitions and career termination. In G. Tenenbaum & R.C. Eklund (Eds.), Handbook of sport psychology (3rd ed., pp. 712–736). New York, NY: Wiley.
  • Backhouse, S., & Mc Kenna, J. (2012). Reviewing coaches' knowledge, attitudes and beliefs regarding doping in sport. International Journal of Sports Science & Coaching, 7, 167–176.
  • Boschen, M.J. (2008). Paruresis (psychogenic inhibition of micturition): Cognitive behavioral formulation and treatment. Depression and Anxiety, 25, 903–912.
  • Budgett, R. (1998). Fatigue and underperformance in athletes: The overtraining syndrome. British Journal of Sports Medicine, 32, 107–110.
  • Corrigan, B., & Kazlauskas, R. (2000). Drug testing at the Sydney Olympics. The Medical Journal of Australia, 173, 312–313.
  • Donovan, R.J., Egger, G., Kapernick, V., & Mendoza, J. (2002). A conceptual framework for achieving performance enhancing drug compliance in sport. Sports Medicine, 32, 269–284.
  • Elbe, A.-M., & Brand, R. (2014). Urination difficulties during doping controls: An act of rebellion? Journal of Clinical Sport Psychology, 8, 204–214.
  • Elbe, A.-M., Nylansted Jensen, S., Elsborg, P., Wetzke, M., Woldemariam, G.A., Huppertz, B., … Butch, A.W. (in press). The urine marker: An innovative method to improve urine doping control procedures. Sports Medicine.
  • Elbe, A.-M., & Overbye, M. (2014). Urine doping controls: The athletes' perspective. International Journal of Sport Policy and Politics, 6, 227–240.
  • Elbe, A.-M., Schlegel, M.M., & Brand, R. (2012). Psychogenic urine retention during doping controls: Consequences for elite athletes. Performance Enhancement & Health, 1(2), 66–74.
  • Gauchel, G., Huppertz, B., Feiertag, H., & Keller, R. (2003). Clinical use of polyethylene glycols as marker substances and determination in urine by liquid chromatography. Journal of Chromatography B, 787, 271–279.
  • Huppertz, B., Gauchel, G., Feiertag, H., Schweizer, H., Krieger, H., Richter, F., …, Keller, R. (2004). Urine labeling with orally applied marker substances in drug substitution therapy. Clinical Chemistry and Laboratory Medicine, 42, 621–626.
  • Kallus, K.W. (1992). Beanspruchung und Ausgangszustand [Strain and initial state]. Weinheim: PVU.
  • Kellmann, M. (2002). Underrecovery and overtraining: Different concepts—similar impact? In M. Kellmann (Ed.), Enhancing recovery: Preventing underperformance in athletes (pp. 3–24). Champaign, IL: Human Kinetics.
  • Malouff, J.M., & Lanyon, R.I. (1985). Avoidant paruresis: An exploratory study. Behavior Modification, 9, 225–234.
  • Mazanov, J., Backhouse, S., Connor, J., Hemphill, D., & Quirk, F. (2014). Athlete support personnel and anti-doping: Knowledge, attitudes, and ethical stance. Scandinavian Journal of Medicine and Science in Sports, 24, 846–856.
  • Nielsen, M.K. (2011, November 14). Triatlet blev nøgenchikaneret i Japan [Triathlete harassed while naked in Japan]. BT. Retrieved from http://www.bt.dk/oevrig-sport/triatlet-blev-noegenchikaneret-i-japan
  • Overbye, M. (2013). Doping og anti-doping i kontekst. En analyse af eliteidrætsudøveres oplevelse af anti-doping policy, betydende faktorer for til- eller fravalg af doping, (u)lovlige præstationsfremmende midler, grænser og dilemmaer [Doping and anti-doping in context: An investigation of elite athletes' experience of anti-doping policy, factors that may facilitate or deter use of doping, (il)legal performance-enhancing substances and methods, grey zones and dilemmas], (Doctoral dissertation). University of Copenhagen, Denmark.
  • Overbye, M., & Wagner, U. (2014). Experiences, attitudes and trust: An inquiry into elite athletes' perception of the whereabouts reporting system. International Journal of Sport Policy and Politics, 3, 407–428.
  • Peters, C., Postler, T., & Oberhoffer, R. (2013Dopingkontrollen in Deutschland: Eine Befragung von Athleten und Dopingkontrolleuren [Doping control in Germany: A survey of athletes and doping control officers]. Sportwissenschaft, 43, 20–33.
  • Sharma, R. (2015). A wee delay: Pique misses Barca flight home from Munich because drug test took too long. Retrieved from http://www.dailymail.co.uk/sport/football/article-2313999/Gerard-Pique-misses-Barcelona-flight-home-drug-test-took-long.html.
  • Soifer, S., Himle, J., & Walsh, K. (2010). Paruresis (shy bladder syndrome): A cognitive-behavioral treatment approach. Social Work in Health Care, 49, 494–507.
  • Strahler, K., & Elbe, A.-M. (2007). Wollen—aber nicht können: das Problem Dopingkontrolle [Wanting—but not being able to: The problem doping control]. Leistungssport, 37(4), 35–38.
  • Strahler, K., & Elbe, A.-M. (2009). Entwicklung einer Skala zur Erfassung psychogenen Harnverhaltens bei Athletinnen und Athleten während der Dopingkontrollen [Development of a scale to measure psychogenic urination difficulties of athletes during doping controls]. Zeitschrift für Sportpsychologie, 16, 156–160.
  • Williams, G.W., & Degenhardt, E.T. (1954). Paruresis: A survey of a disorder of micturition. The Journal of General Psychology, 51, 19–29.
  • World Anti-Doping Agency. (2012). 2012 Anti-doping testing figures report. Retrieved from https://wada-main-prod.s3.amazonaws.com/resources/files/WADA-2012-Anti-Doping-Testing-Figures-Report-EN.pdf
  • World Anti-Doping Agency. (2013). Anti-Doping testing figures. Retrieved from https://wada-main-prod.s3.amazonaws.com/resources/files/WADA-2013-Anti-Doping-Testing-Figures-ABP-REPORT-BLOOD-ANALYSIS.pdf
  • World Anti-Doping Agency. (2014). ISTI urine sample collection guidelines. Retrieved from https://wada-main-prod.s3.amazonaws.com/resources/files/wada_guidelines_urine_sample_collection_2014_v1.0_en.pdf
  • World Anti-Doping Agency. (2015). The doping control process. Retrieved from https://wada-main-prod.s3.amazonaws.com/wada_doping_control_aag_eng_web.pdf
  • Zgourides, G.D. (1987). Paruresis: Overview and implications for treatment. Psychological Reports, 60, 1171–1176.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.